La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « vitro »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
vitamins < vitro < vivo  Facettes :

List of bibliographic references indexed by vitro

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000731 (2015) Zaijun Zhang [République populaire de Chine] ; Guohui Li [République populaire de Chine] ; Samuel S W. Szeto [République populaire de Chine] ; Cheong Meng Chong [République populaire de Chine] ; Quan Quan [République populaire de Chine] ; Chen Huang [République populaire de Chine] ; Wei Cui [République populaire de Chine] ; Baojian Guo [République populaire de Chine] ; Yuqiang Wang [République populaire de Chine] ; Yifan Han [République populaire de Chine] ; K W Michael Siu [Canada] ; Simon Ming Yuen Lee [République populaire de Chine] ; Ivan K. Chu [République populaire de Chine]Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease.
001150 (2012) David He [Canada] ; Ming Miao ; Eva E. Sitarz ; Lisa D. Muiznieks ; Sean Reichheld ; Richard J. Stahl ; Fred W. Keeley ; John ParkinsonPolymorphisms in the human tropoelastin gene modify in vitro self-assembly and mechanical properties of elastin-like polypeptides.
001182 (2012) C J Yong-Kee [Canada] ; E. Sidorova ; A. Hanif ; G. Perera ; J E NashMitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease.
001956 (2011) Ngoc-Duc Doan [Canada] ; Steve Bourgault [Canada] ; Agnieszka Dejda [Canada] ; Myriam Letourneau [Canada] ; Michel Detheux [Belgique] ; David Vaudry [Canada, France] ; Hubert Vaudry [Canada, France] ; David Chatenet [Canada] ; Alain Fournier [Canada]Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects
001A65 (2010) Sadayuki Hashioka [Canada] ; Andis Klegeris ; Claudia Schwab ; Sheng Yu ; Patrick L. McgeerDifferential expression of interferon-gamma receptor on human glial cells in vivo and in vitro.
002109 (2009) Sandra Lourenssen [Canada] ; Kurtis G. Miller [Canada] ; Michael G. Blennerhassett [Canada]Discrete responses of myenteric neurons to structural and functional damage by neurotoxins in vitro
002518 (2007) Koichi Hara [Géorgie (pays)] ; Noriyuki Matsukawa [Géorgie (pays)] ; Takao Yasuhara [Géorgie (pays)] ; Lin Xu [Géorgie (pays)] ; Guolong Yu [Géorgie (pays)] ; Mina Maki [Géorgie (pays)] ; Takeshi Kawase [Japon] ; David C. Hess [Géorgie (pays)] ; Seung U. Kim [Corée du Sud, Canada] ; Cesar V. Borlongan [Géorgie (pays)]Transplantation of post‐mitotic human neuroteratocarcinoma‐overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: In vitro evidence of expedited neuronal differentiation and GDNF secretion
002687 (2007) L. Borgal [Canada] ; M. Hong [Canada] ; D. Sadi [Canada] ; I. Mendez [Canada]Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro
002825 (2006) Ljiljana Krizanac-Bengez [États-Unis] ; Marc R. Mayberg [États-Unis] ; Edwin Cunningham [États-Unis] ; Mohammed Hossain [États-Unis] ; Stephen Ponnampalam [États-Unis] ; Fiona E. Parkinson [Canada] ; Damir Janigro [États-Unis]Loss of shear stress induces leukocyte‐mediated cytokine release and blood–brain barrier failure in dynamic in vitro blood–brain barrier model
002D45 (2004) Sharmila Alam [Canada] ; Arindom Sen [Canada] ; Leo A. Behie [Canada] ; Michael S. Kallos [Canada]Cell cycle kinetics of expanding populations of neural stem and progenitor cells in vitro
002D53 (2003) Fiona E. Parkinson [Canada] ; Jessica Friesen ; Ljiljana Krizanac-Bengez ; Damir JanigroUse of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.
002E59 (2003) Hongxia Li [Canada] ; Jan P. Boon [Pays-Bas] ; Wilma E. Lewis [Pays-Bas] ; Martin Van Den Berg [Pays-Bas] ; Madeleine Nyman [Finlande] ; Robert J. Letcher [Canada, Pays-Bas, Finlande]Hepatic microsomal cytochrome P450 enzyme activity in relation to in vitro metabolism/inhibition of polychlorinated biphenyls and testosterone in Baltic grey seal (Halichoerus grypus)
003201 (2001) Stéphane Méthot [Canada] ; Véronique Moulin [Canada] ; Denis Rancourt [Canada] ; Michel Bourdages [Canada] ; Daniel Goulet [Canada] ; Michel Plante [Canada] ; Francois A. Auger [Canada] ; Lucie Germain [Canada]Morphological changes of human skin cells exposed to a DC electric field in vitro using a new exposure system
003217 (2001) L. A. Kowalski [Canada] ; K. P. Assi [Canada] ; R. K. Wee [Canada] ; Z. Madden [Canada]In vitro prediction of carcinogenicity using a bovine papillomavirus DNA–carrying C3H/10T½ cell line (T1). II: Results from the testing of 100 chemicals
003265 (2001) Christopher J. D. Sinclair [Canada] ; Ljiljana Krizanac-Bengez [États-Unis] ; Kathë A. Stanness [États-Unis] ; Damir Janigro [États-Unis] ; Fiona E. Parkinson [Canada]Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole
003486 (2000) L. A. Kowalski [Canada] ; A. M. Laitinen [Canada] ; B. Mortazavi-Asl [Canada] ; R. K. Wee [Canada] ; H. E. Erb [Canada] ; K. P. Assi [Canada] ; Z. Madden [Canada]In vitro determination of carcinogenicity of sixty‐four compounds using a bovine papillomavirus DNA‐carrying C3H/10T½ cell line
003531 (2000) Tip W. Loo [Canada] ; David M. Clarke [Canada]Blockage of Drug Resistance In Vitro by Disulfiram, a Drug Used to Treat Alcoholism
003541 (2000) H. Li [Canada] ; J. L Henry [Canada]Adenosine receptor blockade reveals N -methyl-d-aspartate receptor- and voltage-sensitive dendritic spikes in rat hippocampal CA1 pyramidal cells in vitro
003607 (1999) C P Granvil [Canada] ; A. Madan ; M. Sharkawi ; A. Parkinson ; I W WainerRole of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.
003C10 (1997) Patrick L. Mcgeer [Canada] ; Douglas G. Walker [Canada] ; Robert E. Pitas [États-Unis] ; Robert W. Mahley [États-Unis] ; Edith G. Mcgeer [Canada]Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro
003E45 (1996) Giuseppe Moretto ; Douglas G. Walker [États-Unis] ; Paola Lanteri ; Federica Taioli ; Stefano Zaffagnini ; Ren Y. Xu [États-Unis] ; Nicolo RizzutoExpression and regulation of glial-cell-line-derived neurotrophic factor (GDNF) mRNA in human astrocytes in vitro

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "vitro" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "vitro" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    vitro
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022